Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
64 hedge funds and large institutions have $288M invested in Flexion Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 14 closing their positions.
354% more call options, than puts
Call options by funds: $4.67M | Put options by funds: $1.03M
75% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 16
22% more capital invested
Capital invested by funds: $236M → $288M (+$52.3M)
9% less funds holding
Funds holding: 70 → 64 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$9.11M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.52M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$2.55M |
| 4 |
JP Morgan Chase
New York
|
+$1.97M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$15.4M |
| 2 |
BC
Broadfin Capital
New York
|
-$4.8M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.56M |
| 4 |
Morgan Stanley
New York
|
-$2.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.98M |
FLXN Hedge Fund Activity: Q4 2015 in Review
64 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2015, worth a combined $288M — up 22% from $236M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FLXN and 8 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 28 added.
The largest buyer was Bank of New York Mellon, adding an estimated $9.11M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $15.4M sold.
- 64 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2015, down from 70 in Q3 2015.
- Funds reported $288M of Flexion Therapeutics, Inc. stock for Q4 2015, up 22% quarter-over-quarter.
- 8 funds opened new Flexion Therapeutics, Inc. positions in Q4 2015 and 14 closed out, a net change of -6 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2015 was Bank of New York Mellon, an estimated $9.11M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2015 was Novo Holdings A/S, an estimated $15.4M sold.
Based on aggregated 13F filings for Q4 2015.